PH12012501053A1 - New azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
PH12012501053A1
PH12012501053A1 PH1/2012/501053A PH12012501053A PH12012501053A1 PH 12012501053 A1 PH12012501053 A1 PH 12012501053A1 PH 12012501053 A PH12012501053 A PH 12012501053A PH 12012501053 A1 PH12012501053 A1 PH 12012501053A1
Authority
PH
Philippines
Prior art keywords
compounds
hex
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
PH1/2012/501053A
Other languages
English (en)
Inventor
Pierre Lestage
Alain Dhainaut
Fany Panayi
Patrick Casara
Jean-Michel Henlin
Anne-Marie Chollet
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42711699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12012501053(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PH12012501053A1 publication Critical patent/PH12012501053A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH1/2012/501053A 2009-12-09 2010-12-08 New azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them PH12012501053A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0905953A FR2953521B1 (fr) 2009-12-09 2009-12-09 Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2010/000823 WO2011070253A1 (fr) 2009-12-09 2010-12-08 Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
PH12012501053A1 true PH12012501053A1 (en) 2013-02-04

Family

ID=42711699

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/501053A PH12012501053A1 (en) 2009-12-09 2010-12-08 New azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US20120283245A1 (enExample)
EP (1) EP2509947A1 (enExample)
JP (1) JP2013513589A (enExample)
KR (1) KR20120102763A (enExample)
CN (1) CN102652127A (enExample)
AP (1) AP2012006352A0 (enExample)
AR (1) AR079265A1 (enExample)
AU (1) AU2010329762B2 (enExample)
BR (1) BR112012013666A2 (enExample)
CA (1) CA2782469C (enExample)
CL (1) CL2012001479A1 (enExample)
CO (1) CO6541535A2 (enExample)
CR (1) CR20120286A (enExample)
CU (1) CU20120091A7 (enExample)
EA (1) EA201200849A1 (enExample)
EC (1) ECSP12011950A (enExample)
FR (1) FR2953521B1 (enExample)
GE (1) GEP20156227B (enExample)
IN (1) IN2012DN04966A (enExample)
MA (1) MA33882B1 (enExample)
MX (1) MX2012006578A (enExample)
NI (1) NI201200099A (enExample)
PE (1) PE20121475A1 (enExample)
PH (1) PH12012501053A1 (enExample)
SA (1) SA110320011B1 (enExample)
SG (1) SG181082A1 (enExample)
TN (1) TN2012000267A1 (enExample)
TW (1) TW201200499A (enExample)
UA (1) UA102950C2 (enExample)
UY (1) UY33072A (enExample)
WO (1) WO2011070253A1 (enExample)
ZA (1) ZA201203943B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016529307A (ja) * 2013-09-09 2016-09-23 サノフイ アルツハイマー病の処置に使用するためのｈ３受容体アンタゴニスト

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
ATE466007T1 (de) * 2005-11-30 2010-05-15 Hoffmann La Roche 5-substituierte indol-2-carbonsäureamidderivate

Also Published As

Publication number Publication date
WO2011070253A8 (fr) 2012-08-02
EP2509947A1 (fr) 2012-10-17
SG181082A1 (en) 2012-07-30
CA2782469C (fr) 2014-04-08
AU2010329762A1 (en) 2012-06-21
ECSP12011950A (es) 2012-07-31
WO2011070253A1 (fr) 2011-06-16
AP2012006352A0 (en) 2012-08-31
IN2012DN04966A (enExample) 2015-09-25
JP2013513589A (ja) 2013-04-22
GEP20156227B (en) 2015-01-26
EA201200849A1 (ru) 2013-01-30
CU20120091A7 (es) 2012-07-31
CN102652127A (zh) 2012-08-29
BR112012013666A2 (pt) 2016-04-19
CL2012001479A1 (es) 2013-02-08
FR2953521A1 (fr) 2011-06-10
AU2010329762B2 (en) 2013-10-03
ZA201203943B (en) 2013-08-28
AR079265A1 (es) 2012-01-04
US20120283245A1 (en) 2012-11-08
TN2012000267A1 (fr) 2013-12-12
CR20120286A (es) 2012-08-20
FR2953521B1 (fr) 2011-11-18
TW201200499A (en) 2012-01-01
UA102950C2 (ru) 2013-08-27
SA110320011B1 (ar) 2013-10-01
CO6541535A2 (es) 2012-10-16
MX2012006578A (es) 2012-06-25
PE20121475A1 (es) 2012-10-20
NI201200099A (es) 2012-11-09
CA2782469A1 (fr) 2011-06-16
KR20120102763A (ko) 2012-09-18
MA33882B1 (fr) 2013-01-02
UY33072A (es) 2011-05-31

Similar Documents

Publication Publication Date Title
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
MY149731A (en) Compounds
MX2011012337A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de cancer y de otras enfermedades.
TW200745067A (en) Novel compounds
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
MX336381B (es) Boronatos como inhibidores de arginasa.
EP2536736A4 (en) PREPARATION OF 6'-O-SIALYLLACTOSE AND INTERMEDIATE PRODUCTS THEREOF
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
NZ593951A (en) Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
MY183588A (en) New salvianolic acid compound l, preparation method and use thereof
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
MX2010008051A (es) Nuevos derivados de fluoroglicosidos aromaticos, productos farmaceuticos que comprenden dichos compuestos y uso de los mismos.
MX2012013274A (es) Novedosos derivados de la pirimidina.
IN2012DN01292A (enExample)
UA98623C2 (ru) Соединения диосметина, способ их получения и фармацевтическая композиция, которая их содержит
WO2011047055A3 (en) Novel mek inhibitors, useful in the treatment of diseases
TW200626593A (en) Novel compounds
IN2011KN05169A (enExample)
TW200833335A (en) New pyridine analogues
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
MY150497A (en) New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
MX2013006670A (es) Derivado de 2-carboxamida-4-piperazinil-benzofurano.